Lichen Planopilaris Clinical Trials in New York, New York
2 recruitingNew York, New York
Showing 1–2 of 2 trials
Recruiting
Phase 2
Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris
Central Centrifugal Cicatricial AlopeciaLichen Planopilaris
Icahn School of Medicine at Mount Sinai30 enrolled1 locationNCT07487948
Recruiting
Phase 2Phase 3
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Lichen Planopilaris
Priovant Therapeutics, Inc.342 enrolled61 locationsNCT07532603